Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients Caregivers Providers
Log In Ask a Question
PubMed This is a summary of 24 peer-reviewed journal articles Updated
Genetics

Primary vs Secondary Carnitine Deficiency Explained

At a Glance

Primary carnitine deficiency is a genetic disorder where a defective transporter causes the body to lose carnitine. Secondary carnitine deficiency occurs when a normal transport system is depleted by outside factors like medications, severe dietary restrictions, or other metabolic disorders.

In this answer

3 sections

01

Primary Carnitine Deficiency: A Genetic Transporter Defect

02

Secondary Carnitine Deficiency: Depletion from Other Causes

03

How Doctors Tell Them Apart: The Acylcarnitine Profile

The difference between primary and secondary carnitine deficiency lies in the underlying cause. Systemic Primary Carnitine Deficiency (SPCD) is an inherited genetic defect that prevents the body from transporting and holding onto carnitine [1][2]. In contrast, secondary carnitine deficiency means the body’s carnitine transport system works normally, but carnitine levels have dropped due to an outside factor—such as another metabolic disorder, certain medications, or severe dietary restrictions [3][4]. While both result in abnormally low carnitine levels in the blood, they require different diagnostic approaches and different long-term management strategies.

Primary Carnitine Deficiency: A Genetic Transporter Defect

Primary carnitine deficiency is an inherited condition caused by mutations in the SLC22A5 gene [1][2]. This gene provides the instructions for making a transport protein called OCTN2. This protein acts as a pump that actively transports carnitine into the body’s cells and prevents it from being lost in the urine [2][1].

When the OCTN2 transporter is defective, the kidneys fail to reabsorb carnitine, accidentally flushing it out into the urine [2][5]. Because the body cannot retain carnitine or move it into cells, tissues that rely heavily on fats for energy—such as the heart and skeletal muscles—are left depleted. Without enough carnitine, this can lead to muscle weakness, low blood sugar, or heart problems (cardiomyopathy) [2][6]. Fortunately, these symptoms often improve rapidly once L-carnitine supplementation is started [7][8].

Secondary Carnitine Deficiency: Depletion from Other Causes

In secondary carnitine deficiency, the genetic blueprint for the carnitine transporter is perfectly normal. Instead, carnitine is depleted by other forces that either drain the body’s supply or prevent it from absorbing enough. Common causes include:

  • Other metabolic disorders: In conditions like fatty acid oxidation disorders or organic acidemias, abnormal metabolic byproducts build up in the body. Carnitine binds to these toxic byproducts to help flush them out of the system, which quickly drains the body’s carnitine reserves [9][10].
  • Specific medications: Certain drugs are notorious for causing secondary carnitine deficiency. The anti-seizure medication valproic acid increases carnitine loss in the urine [11][4]. Similarly, antibiotics containing pivalic acid bind to carnitine and force the body to excrete it, effectively robbing the body of its free carnitine pool [12][13].
  • Medical procedures and severe dietary limits: Long-term medical treatments, such as hemodialysis or continuous intravenous feeding (total parenteral nutrition, or TPN), can slowly drain the body’s carnitine over time [14][15]. Severe malnutrition or highly restrictive diets can also lead to secondary deficiency, as the body isn’t taking in enough building blocks to maintain normal levels [16][17].

How Doctors Tell Them Apart: The Acylcarnitine Profile

Because the symptoms of primary and secondary carnitine deficiency can look similar, doctors use a specialized blood test called an acylcarnitine profile to tell them apart [18][19]. This test measures both “free” carnitine (carnitine traveling alone, often listed as C0 on lab reports) and acylcarnitines (carnitine that is bound to fats or other molecules).

  • In Primary Carnitine Deficiency: The blood test will show profoundly low levels of free carnitine (C0), along with equally low levels of all other acylcarnitines [20][21]. The body simply doesn’t have enough carnitine of any kind.
  • In Secondary Carnitine Deficiency: Free carnitine levels will be low, but the test will often show an abnormal buildup of specific acylcarnitines [9][13]. This buildup serves as a “fingerprint” showing exactly which medication or underlying metabolic disorder is trapping the carnitine [18][12].

To confirm a diagnosis of primary carnitine deficiency, doctors will usually follow up with genetic testing to look for mutations in the SLC22A5 gene [21][22]. They may also test the urine to see if the kidneys are improperly excreting massive amounts of carnitine [23].

While both primary and secondary carnitine deficiency may be treated with L-carnitine supplements, treating secondary deficiency inherently requires addressing its root cause, such as adjusting a medication or managing an underlying metabolic condition [24][3].

Common questions in this guide

What causes primary carnitine deficiency?
Primary carnitine deficiency is an inherited genetic condition caused by mutations in the SLC22A5 gene. This mutation creates a defective transport protein, preventing the body from moving carnitine into cells and causing the kidneys to accidentally flush it out in urine.
Can medications cause low carnitine levels?
Yes, certain medications can cause secondary carnitine deficiency. Drugs like the anti-seizure medication valproic acid and antibiotics containing pivalic acid bind to carnitine and force the body to excrete it in your urine.
How do doctors test for carnitine deficiency?
Doctors typically start with a specialized blood test called an acylcarnitine profile, which measures both free and bound carnitine levels. They may also use genetic testing or urine tests to confirm whether the deficiency is primary or secondary.
What is the difference in test results between primary and secondary deficiency?
In primary carnitine deficiency, blood tests show profoundly low levels of both free carnitine and all other types of bound carnitine. In secondary deficiency, free carnitine is low, but specific types of bound carnitine are often elevated depending on the underlying cause.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Given my test results, are we looking at primary carnitine deficiency or a secondary cause?
  2. 2.What did my acylcarnitine profile show regarding the balance of free carnitine (C0) versus other acylcarnitines?
  3. 3.Could any of my current medications, such as valproic acid or certain antibiotics, be contributing to low carnitine levels?
  4. 4.Do we need to perform genetic testing for the SLC22A5 gene to confirm a primary diagnosis?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

Related questions

Does a Baby's Positive SPCD Screen Mean the Mother Has It?Can Diet Alone Treat Primary Carnitine Deficiency?Do I Need Treatment For SPCD If I Have No Symptoms?How Does SPCD Affect the Heart and Cause Arrhythmias?How Do You Stop Fishy Body Odor from L-Carnitine?Is Systemic Primary Carnitine Deficiency Hereditary?Is SPCD Linked to Autism or Developmental Delays?Is There a Cure for Systemic Primary Carnitine Deficiency?What Are Common SPCD Misdiagnoses?What Are the Fasting Guidelines for SPCD Patients?SPCD Pregnancy Risks: Is It Safe to Get Pregnant?What is the SPCD ER Protocol During an Illness?What is the Life Expectancy for Someone with SPCD?Where is Systemic Primary Carnitine Deficiency Most Common?How Often Do You Need Tests for SPCD?What Triggers Muscle Breakdown in Adults With SPCD?Which Doctors Treat Systemic Primary Carnitine Deficiency

References

References (24)
  1. 1

    Molecular investigation in Chinese patients with primary carnitine deficiency.

    Zhang Y, Li H, Liu J, et al.

    Molecular genetics & genomic medicine 2019; (7(9)):e901 doi:10.1002/mgg3.901.

    PMID: 31364285
  2. 2

    Structural basis of sodium ion-dependent carnitine transport by OCTN2.

    Davies JS, Zeng YC, Briot C, et al.

    Nature communications 2025; (17(1)):181 doi:10.1038/s41467-025-66867-6.

    PMID: 41318751
  3. 3

    Carnitine deficiency in epileptic children treated with a diversity of anti-epileptic regimens.

    El Mously S, Abdel Ghaffar H, Magdy R, et al.

    The Egyptian journal of neurology, psychiatry and neurosurgery 2018; (54(1)):37 doi:10.1186/s41983-018-0033-z.

    PMID: 30546248
  4. 4

    Carnitine Deficiency in Chinese Children with Epilepsy on Valproate Monotherapy.

    Qiliang L, Wenqi S, Hong J

    Indian pediatrics 2018; (55(3)):222-224.

    PMID: 29629695
  5. 5

    Functional activity of L-carnitine transporters in human airway epithelial cells.

    Ingoglia F, Visigalli R, Rotoli BM, et al.

    Biochimica et biophysica acta 2016; (1858(2)):210-9.

    PMID: 26607009
  6. 6

    A case of atypical systemic primary carnitine deficiency in Saudi Arabia.

    Alghamdi A, Almalki H, Shawli A, et al.

    Pediatric reports 2018; (10(2)):7705 doi:10.4081/pr.2018.7705.

    PMID: 30069296
  7. 7

    Primary Carnitine Deficiency: A Rare, Reversible Metabolic Cardiomyopathy.

    Tomlinson S, Atherton J, Prasad S

    Case reports in cardiology 2018; (2018()):3232105 doi:10.1155/2018/3232105.

    PMID: 30302293
  8. 8

    Left ventricular noncompaction cardiomyopathy and short QT syndrome due to primary carnitine deficiency.

    Hanington OP, Armstrong C, Pierre G, et al.

    Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 2023; (28(6)):e13077 doi:10.1111/anec.13077.

    PMID: 37658577
  9. 9

    Elevation of pivaloylcarnitine by sivelestat sodium in two children.

    Yamada K, Kobayashi H, Bo R, et al.

    Molecular genetics and metabolism 2015; (116(3)):192-4.

    PMID: 26428892
  10. 10

    Biochemical Markers for the Diagnosis of Mitochondrial Fatty Acid Oxidation Diseases.

    Ruiz-Sala P, Peña-Quintana L

    Journal of clinical medicine 2021; (10(21)) doi:10.3390/jcm10214855.

    PMID: 34768374
  11. 11

    Risk factors for sodium valproate-induced renal tubular dysfunction.

    Koga S, Kimata T, Yamanouchi S, et al.

    Clinical and experimental nephrology 2018; (22(2)):420-425 doi:10.1007/s10157-017-1472-z.

    PMID: 28836089
  12. 12

    Matrix effect-corrected liquid chromatography/tandem mass-spectrometric method for determining acylcarnitines in human urine.

    Abe K, Suzuki H, Maekawa M, et al.

    Clinica chimica acta; international journal of clinical chemistry 2017; (468()):187-194 doi:10.1016/j.cca.2017.03.001.

    PMID: 28274611
  13. 13

    Hypocarnitinemia Observed in an Infant Treated with Short-Term Administration of Antibiotic Containing Pivalic Acid.

    Nakazaki K, Ogawa E, Ishige M, et al.

    The Tohoku journal of experimental medicine 2018; (244(4)):279-282 doi:10.1620/tjem.244.279.

    PMID: 29628457
  14. 14

    Carnitine deficiency in children receiving continuous renal replacement therapy.

    Sgambat K, Moudgil A

    Hemodialysis international. International Symposium on Home Hemodialysis 2016; (20(1)):63-7 doi:10.1111/hdi.12341.

    PMID: 26265013
  15. 15

    l-carnitine: Nutrition, pathology, and health benefits.

    Alhasaniah AH

    Saudi journal of biological sciences 2023; (30(2)):103555 doi:10.1016/j.sjbs.2022.103555.

    PMID: 36632072
  16. 16

    Carnitine deficiency in preterm infants: A national survey of knowledge and practices.

    Clark MA, Stein REK, Silver EJ, et al.

    Journal of neonatal-perinatal medicine 2017; (10(4)):381-386 doi:10.3233/NPM-16146.

    PMID: 29286927
  17. 17

    Diagnosis of Carnitine Deficiency in Extremely Preterm Neonates Related to Parenteral Nutrition: Two Step Newborn Screening Approach.

    Ramaswamy M, Anthony Skrinska V, Fayez Mitri R, Abdoh G

    International journal of neonatal screening 2019; (5(3)):29 doi:10.3390/ijns5030029.

    PMID: 33072988
  18. 18

    Clinical, biochemical, and molecular genetic characteristics of patients with primary carnitine deficiency identified by newborn screening in Shanghai, China.

    Chang S, Yang Y, Xu F, et al.

    Frontiers in genetics 2022; (13()):1062715 doi:10.3389/fgene.2022.1062715.

    PMID: 36568374
  19. 19

    Selective and accurate C5 acylcarnitine quantitation by UHPLC-MS/MS: Distinguishing true isovaleric acidemia from pivalate derived interference.

    Minkler PE, Stoll MSK, Ingalls ST, Hoppel CL

    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2017; (1061-1062()):128-133 doi:10.1016/j.jchromb.2017.07.018.

    PMID: 28734160
  20. 20

    Gene spectrum and clinical traits of 10 patients with primary carnitine deficiency.

    Chen Y, Lin Q, Zeng Y, et al.

    Molecular genetics & genomic medicine 2021; (9(2)):e1583 doi:10.1002/mgg3.1583.

    PMID: 33560599
  21. 21

    [Genetic diagnosis of 10 neonates with primary carnitine deficiency].

    Tan JQ, Chen DY, Li ZT, et al.

    Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics 2017; (19(11)):1150-1154.

    PMID: 29132460
  22. 22

    Newborn screening of primary carnitine deficiency: clinical and molecular genetic characteristics.

    Hu H, Ma Q, Wang Y, et al.

    Italian journal of pediatrics 2025; (51(1)):70 doi:10.1186/s13052-025-01911-1.

    PMID: 40069787
  23. 23

    Benefits and pitfalls in newborn screening for carnitine uptake deficiency: a 4-year single-center experience.

    Turturo M, Rossi A, Barretta F, et al.

    Orphanet journal of rare diseases 2025; (21(1)).

    PMID: 41310792
  24. 24

    Primary carnitine deficiency with severe acute hepatitis following rotavirus gastroenteritis.

    Ishige M, Fuchigami T, Furukawa M, et al.

    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2019; (25(11)):913-916 doi:10.1016/j.jiac.2019.04.020.

    PMID: 31189503

This page explains the differences between primary and secondary carnitine deficiency for educational purposes only. Always consult your doctor or a metabolic specialist for accurate diagnosis and medical advice.

Get notified when new evidence is published on Systemic primary carnitine deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.